Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells

References

Ashburner, B.P., Westerheide, S.D., and Baldwin, A.S., Jr. (2001). The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol. 21, 7065–7077.10.1128/MCB.21.20.7065-7077.2001Search in Google Scholar

Baldwin, A.S., Jr. (1996). The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649–683.10.1146/annurev.immunol.14.1.649Search in Google Scholar

Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129, 823–837.10.1016/j.cell.2007.05.009Search in Google Scholar

Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2, 257–280.10.1158/1541-7786.257.2.5Search in Google Scholar

Camarero, N., Nadal, A., Barrero, M.J., Haro, D., and Marrero, P.F. (2003). Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. Nucleic Acids Res. 31, 1693–1703.10.1093/nar/gkg262Search in Google Scholar

Chen, L.F., Mu, Y., and Greene, W.C. (2002). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21, 6539–6548.10.1093/emboj/cdf660Search in Google Scholar

Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265–312.10.1080/10408360490471931Search in Google Scholar

Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C.S., Choe, Y., Bode, W., and Goettig, P. (2006). Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678–25688.10.1074/jbc.M602372200Search in Google Scholar

Fujioka, S., Sclabas, G.M., Schmidt, C., Niu, J., Frederick, W.A., Dong, Q.G., Abbruzzese, J.L., Evans, D.B., Baker, C., and Chiao, P.J. (2003). Inhibition of constitutive NF-κB activity by IκB αM suppresses tumorigenesis. Oncogene 22, 1365–1370.10.1038/sj.onc.1206323Search in Google Scholar

Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B., and Wang, K. (2000). Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257, 119–130.10.1016/S0378-1119(00)00382-6Search in Google Scholar

Gao, C., Li, X., Lam, M., Liu, Y., Chakraborty, S., and Kao, H.Y. (2006). CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s. FEBS Lett. 580, 5096–5104.10.1016/j.febslet.2006.08.038Search in Google Scholar

Grozinger, C.M., Chao, E.D., Blackwell, H.E., Moazed, D., and Schreiber, S.L. (2001). Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276, 38837–38843.10.1074/jbc.M106779200Search in Google Scholar

Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R., and Young, R.A. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 77–88.10.1016/j.cell.2007.05.042Search in Google Scholar

Harvey, T.J., Hooper, J.D., Myers, S.A., Stephenson, S.A., Ashworth, L.K., and Clements, J.A. (2000). Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397–37406.10.1074/jbc.M004525200Search in Google Scholar

Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R., Linehan, W.M., et al. (1994). Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91, 9700–9704.10.1073/pnas.91.21.9700Search in Google Scholar

Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51–59.10.1016/0378-1119(89)90358-2Search in Google Scholar

Huang, B.H., Laban, M., Leung, C.H., Lee, L., Lee, C.K., Salto-Tellez, M., Raju, G.C., and Hooi, S.C. (2005a). Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 12, 395–404.10.1038/sj.cdd.4401567Search in Google Scholar PubMed

Huang, W., Zhao, S., Ammanamanchi, S., Brattain, M., Venkatasubbarao, K., and Freeman, J.W. (2005b). Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280, 10047–10054.10.1074/jbc.M408680200Search in Google Scholar PubMed

Iakovlev, V., Siegel, E.R., Tsao, M.S., and Haun, R.S. (2012). Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 21, 1135–1142.10.1158/1055-9965.EPI-11-1079Search in Google Scholar PubMed

Ishii, S., Kurasawa, Y., Wong, J., and Yu-Lee, L.Y. (2008). Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment. Proc. Natl. Acad. Sci. USA. 105, 4179–4184.10.1073/pnas.0710140105Search in Google Scholar PubMed PubMed Central

Johnson, S.K., Ramani, V.C., Hennings, L., and Haun, R.S. (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109, 1811–1820.10.1002/cncr.22606Search in Google Scholar PubMed

Kim, S.Y., Woo, M.S., Kim, W.K., Choi, E.C., Henson, J.W., and Kim, H.S. (2003). Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors. J. Virol. 77, 3394–3401.10.1128/JVI.77.6.3394-3401.2003Search in Google Scholar

Kobari, M., Hisano, H., Matsuno, S., Sato, T., Kan, M., and Tachibana, T. (1986). Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. Tohoku. J. Exp. Med. 150, 231–248.10.1620/tjem.150.231Search in Google Scholar PubMed

Lee, C. and Huang, C.H. (2013). LASAGNA-Search: an integrated web tool for transcription factor binding site search and visualization. Biotechniques 54, 141–153.10.2144/000113999Search in Google Scholar PubMed

Lee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., and Seto, E. (2006). Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation. Mol. Cell Biol. 26, 5259–5269.10.1128/MCB.01971-05Search in Google Scholar PubMed PubMed Central

Li, L.C. and Dahiya, R. (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics (Oxford) 18, 1427–1431.10.1093/bioinformatics/18.11.1427Search in Google Scholar PubMed

Liu, F., Dowling, M., Yang, X.J., and Kao, G.D. (2004). Caspase-mediated specific cleavage of human histone deacetylase 4. J. Biol. Chem. 279, 34537–34546.10.1074/jbc.M402475200Search in Google Scholar PubMed

Pakneshan, P., Szyf, M., Farias-Eisner, R., and Rabbani, S.A. (2004). Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem. 279, 31735–31744.10.1074/jbc.M401669200Search in Google Scholar PubMed

Pampalakis, G. and Sotiropoulou, G. (2006). Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol. Chem. 387, 773–782.10.1515/BC.2006.097Search in Google Scholar PubMed

Patra, S.K., Deb, M. and Patra, A. (2011). Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin. Epigenetics 2, 27–53.10.1007/s13148-010-0016-0Search in Google Scholar PubMed PubMed Central

Philip, S., Zahoor, M.A., Zhi, H., Ho, Y.K. and Giam, C.Z. (2014). Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog 10, e1004040.10.1371/journal.ppat.1004040Search in Google Scholar PubMed PubMed Central

Planque, C., de Monte, M., Guyetant, S., Rollin, J., Desmazes, C., Panel, V., Lemarie, E., and Courty, Y. (2005). KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Biochem. Biophys. Res. Commun. 329, 1260–1266.10.1016/j.bbrc.2005.02.100Search in Google Scholar PubMed

Pokholok, D.K., Harbison, C.T., Levine, S., Cole, M., Hannett, N.M., Lee, T.I., Bell, G.W., Walker, K., Rolfe, P.A., Herbolsheimer, E., et al. (2005). Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122, 517–527.10.1016/j.cell.2005.06.026Search in Google Scholar PubMed

Pufahl, L., Katryniok, C., Schnur, N., Sorg, B.L., Metzner, J., Grez, M., and Steinhilber, D. (2012). Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. J. Cell Mol. Med. 16, 1461–1473.10.1111/j.1582-4934.2011.01420.xSearch in Google Scholar PubMed PubMed Central

Ramani, V.C. and Haun, R.S. (2008a). Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding. Pancreas 37, 399–404.10.1097/MPA.0b013e31817f76f7Search in Google Scholar PubMed

Ramani, V.C. and Haun, R.S. (2008b). The extracellular matrix protein fibronectin is a substrate for kallikrein 7. Biochem. Biophys. Res. Commun. 369, 1169–1173.10.1016/j.bbrc.2008.03.021Search in Google Scholar PubMed

Ramani, V.C., Hennings, L., and Haun, R.S. (2008). Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 8, 373.10.1186/1471-2407-8-373Search in Google Scholar PubMed PubMed Central

Ramani, V.C., Kaushal, G.P., and Haun, R.S. (2011). Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Biochim. Biophys. Acta Mol. Cell Res. 1813, 1525–1531.10.1016/j.bbamcr.2011.05.007Search in Google Scholar PubMed PubMed Central

Ruckert, F., Hennig, M., Petraki, C.D., Wehrum, D., Distler, M., Denz, A., Schroder, M., Dawelbait, G., Kalthoff, H., Saeger, H.D., et al. (2008). Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Br. J. Cancer 99, 1484–1492.10.1038/sj.bjc.6604717Search in Google Scholar PubMed PubMed Central

Santin, A.D., Cane, S., Bellone, S., Bignotti, E., Palmieri, M., De Las Casas, L.E., Roman, J.J., Anfossi, S., O’Brien, T., and Pecorelli, S. (2004). The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells. Gynecol. Oncol. 94, 283–288.10.1016/j.ygyno.2004.05.023Search in Google Scholar PubMed

Santos-Rosa, H., Schneider, R., Bannister, A.J., Sherriff, J., Bernstein, B.E., Emre, N.C., Schreiber, S.L., Mellor, J., and Kouzarides, T. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419, 407–411.10.1038/nature01080Search in Google Scholar

Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G.F., Alcalay, M., Seiser, C., et al. (2007). Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell Biol. 27, 4784–4795.10.1128/MCB.00494-07Search in Google Scholar

Shukeir, N., Pakneshan, P., Chen, G., Szyf, M., and Rabbani, S.A. (2006). Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res. 66, 9202–9210.10.1158/0008-5472.CAN-06-1954Search in Google Scholar

Sowa, Y., Orita, T., Minamikawa-Hiranabe, S., Mizuno, T., Nomura, H., and Sakai, T. (1999). Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59, 4266–4270.Search in Google Scholar

Strahl, B.D., Ohba, R., Cook, R.G., and Allis, C.D. (1999). Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl. Acad. Sci. USA. 96, 14967–14972.10.1073/pnas.96.26.14967Search in Google Scholar

Talieri, M., Diamandis, E.P., Gourgiotis, D., Mathioudaki, K., and Scorilas, A. (2004). Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb. Haemost. 91, 180–186.10.1160/TH03-05-0261Search in Google Scholar

Tamir, A., Jag, U., Sarojini, S., Schindewolf, C., Tanaka, T., Gharbaran, R., Patel, H., Sood, A., Hu, W., Patwa, R., et al. (2014). Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. J. Ovarian. Res. 7, 109.10.1186/s13048-014-0109-zSearch in Google Scholar

Tanimoto, H., Underwood, L.J., Shigemasa, K., Yan Yan, M.S., Clarke, J., Parmley, T.H., and O’Brien, T. J. (1999). The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86, 2074–2082.10.1002/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.0.CO;2-3Search in Google Scholar

Taniura, S., Kamitani, H., Watanabe, T., and Eling, T.E. (2002). Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277, 16823–16830.10.1074/jbc.M200527200Search in Google Scholar

Walker, F., Nicole, P., Jallane, A., Soosaipillai, A., Mosbach, V., Oikonomopoulou, K., Diamandis, E.P., Magdolen, V., and Darmoul, D. (2014). Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer. Biol. Chem. 395, 1075–1086.10.1515/hsz-2014-0142Search in Google Scholar

Walker, G.E., Wilson, E.M., Powell, D., and Oh, Y. (2001). Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology 142, 3817–3827.10.1210/endo.142.9.8380Search in Google Scholar

Wang, W., Abbruzzese, J.L., Evans, D.B., Larry, L., Cleary, K.R., and Chiao, P.J. (1999). The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5, 119–127.Search in Google Scholar

Xiao, H., Hasegawa, T., and Isobe, K. (1999). Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell Biochem. 73, 291–302.10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184–204.10.1210/edrv.22.2.0424Search in Google Scholar

Zhang, Y., Liao, M., and Dufau, M.L. (2006). Phosphatidylinositol 3-kinase/protein kinase Cζ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression of transcription of the luteinizing hormone receptor gene. Mol. Cell Biol. 26, 6748–6761.10.1128/MCB.00560-06Search in Google Scholar

Zhao, S., Venkatasubbarao, K., Li, S., and Freeman, J.W. (2003). Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor β Type II receptor expression in human pancreatic cancer cells. Cancer Res. 63, 2624–2630.Search in Google Scholar